Company name: Cass Pharmaceuticals Inc. (stylized: CASS Pharmaceuticals)
Amount raised: $1.98 million of a $4.5 million offering
What they do: Founded in 2020, Franklin-based Cass aims to “create a future where effective and comprehensive treatment of diabetes is readily available and affordable,” according to the company’s website. Cass has an insulin program, which utilizes rapid-acting insulin, and a glucagon program, which looks to create a bi-hormonal insulin pump that would enable the…
